Delivery Order SPE2DB22D3301-SPE2DB25FY9AC
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Glucagon 1 mg Emergency Kits with a ceiling value of $1,055.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The contract is scheduled for ultimate completion on August 1, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,163.09 to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of July 30, 2025. This contract utilizes firm fixed pricing and was awarded competitively with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits, with a contract ceiling value of $7,809.84. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed-price pricing under a non-competitive set-aside arrangement. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the procurement of Glucagon 1 mg Emergency Kits, valued at $2,428.73 with a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by July 31, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.87 to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,955.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of August 1, 2025. The award was issued on July 31, 2025, with no set-aside designation, indicating competitive selection. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its Corporate Office location. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,557.64 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits. The contract, executed on July 22, 2025, with an ultimate completion date of July 23, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting military...
- The Defense Logistics Agency awarded a $5,209.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits. This non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a child delivery order under a larger indefinite delivery contract vehicle. The products will be delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 27, 2025, for the supply of Glucagon 1 mg Emergency Kits, with a ceiling value of $3,722.88. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,263.20 to AmerisourceBergen Drug Corp for Glucosan 1 mg Emergency Kits, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9ACDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,088.79 by the Defense Logistics Agency to supply Glucagon 1 mg Emergency Kits. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Defense Logistics Agency's Medical Supply Chain utilizes AmerisourceBergen as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Glucagon emergency kits are essential medications used for treating severe hypoglycemic episodes in patients with diabetes and represent the type of specialized pharmaceutical commodity typically distributed through DLA's medical supply vehicle. The delivery order is competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards and its established role as a major healthcare solutions provider serving the Department of Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 8/7/25 |